Skip to main content
Log in

A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only

  • ASSISTED REPRODUCTION TECHNOLOGIES
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Poter RN, Smith W, Craft IL, et al. Induction of ovulation for in vitro fertilization using buserelin and gonadtropins. Lancet. 1984;2(8414):1284–5.

    Article  Google Scholar 

  2. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;7(2):170–207.

    Article  Google Scholar 

  3. Stanger JD, Yovich JL. Reduced in vitro fertilization of human oocyte from patients with raised basal LH levels during the follicular phase. Br J Obstet Gynaecol. 1985;92:385–93.

    Article  CAS  PubMed  Google Scholar 

  4. Wilcox J, Potter D, Moore M, Ferrande L, Kelly E. Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. Fertil Steril. 2005;84:108–17.

    Article  CAS  PubMed  Google Scholar 

  5. Oliveira JB, Baruffi R, Petersen CG, Mauri AL, Cavagna M, Franco Jr JG. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol. 2010;8:107.

    Article  PubMed  Google Scholar 

  6. Mancini F, Tur R, Martinez F, Coroleu B, Rodríguez I, Barri PN. Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2011;27(3):150–5.

    Article  CAS  PubMed  Google Scholar 

  7. Scott RT, Carey KD, Leland M, Navot D. Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboons. Fertil Steril. 1993;59:1124–8.

    CAS  PubMed  Google Scholar 

  8. Karine C, Robin F, Kristin B, Kamilee C, Richard P. Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development. Fertil Steril. 2011;95:317–9.

    Article  Google Scholar 

  9. Brown JB. Pituitary control of ovarian function–concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol. 1978;18(1):46–54.

    Article  CAS  PubMed  Google Scholar 

  10. Schoemaker J, van Weissen Bruch MM, Scheele F, et al. The FSH threshold concept in clinical ovulation induction. Baillieres Clin Obstet Gynaecol. 1993;7(2):297–308.

    Article  CAS  PubMed  Google Scholar 

  11. Schipper I, Hop WC, Fauser BC. The follicle stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab. 1998;83(4):1292–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guangxiu Lu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gong, F., Cai, S., Zhang, S. et al. A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only. J Assist Reprod Genet 29, 329–330 (2012). https://doi.org/10.1007/s10815-012-9716-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-012-9716-z

Keywords

Navigation